410 Medical Raises $12M in Funding Led by Orlando Health Ventures

The round also saw participation from Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General, and a new undisclosed strategic investor.

The company will use the funding to expand its commercial operations and support the launch of LifeFlow's infusion device.

Read More:F5 Appoints Cathy Peterman as Chief People Officer

410 Medical's LifeFlow products are used by more than 500 hospitals and emergency medical service (EMS) agencies across the United States. The devices help healthcare teams quickly deliver fluids and blood to patients with life-threatening conditions such as sepsis and severe blood loss.

Along with expanding its commercial business, 410 Medical is also investing in the next generation of LifeFlow technology. The company plans to launch a new version of the device in 2027, built using feedback from nearly a decade of working with frontline healthcare professionals.

The new device is designed to improve speed, portability, and ease of use, helping medical teams deliver faster and more effective care to critically ill patients.

"Orlando Health Ventures is proud to lead this round and deepen our partnership with 410 Medical," said Bobby Helmedag, Managing Director of Orlando Health Ventures. "LifeFlow addresses a critical gap in resuscitative care, and we've seen firsthand the impact it can have for clinicians and patients.

"The heightened interest in this round reflects the confidence investors and customers have in 410 Medicals mission and products," said Kyle Chenet, Chief Executive Officer at 410 Medical. With this funding, we're able to expand our commercial reach, bringing LifeFlow to more clinicians and investing in the next generation of our technology.

About 410 Medical

Founded in 2013, 410 Medical is a North Carolina-based medical device company that develops technologies to improve emergency care for critically ill patients. Its flagship product, LifeFlow®, received FDA clearance in 2016 and helps healthcare providers quickly deliver fluids and blood to patients with sepsis, severe blood loss and other life threatening conditions.

Read More:D.A. Davidson & Co. Appoints Garik Shmois as Managing Director